About EvoEndo
EvoEndo is a company based in Englewood (United States) founded in 2017 by Joel Friedlander. It operates as a HealthTech, and Direct-to-Consumer (D2C). EvoEndo has raised $20.75 million across 4 funding rounds from investors including Gastro, Varia Ventures and TLP Investments. EvoEndo offers products and services including EvoEndo Endoscopy System and Ultra-Thin Endoscopes. EvoEndo operates in a competitive market with competitors including Auris Health, MedInTech, Karl Storz, Wooptix and Aohua Endoscopy, among others.
- Headquarter Englewood, United States
- Founders Joel Friedlander
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evoendo, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$20.75 M (USD)
in 4 rounds
-
Latest Funding Round
$2.25 M (USD), Series A
Aug 02, 2024
-
Investors
Gastro
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of EvoEndo
EvoEndo offers a comprehensive portfolio of products and services, including EvoEndo Endoscopy System and Ultra-Thin Endoscopes. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Designed for sedation-free pediatric and adult endoscopy.
High-performance scopes for small anatomy endoscopy procedures.
Unlock access to complete
Unlock access to complete
Funding Insights of EvoEndo
EvoEndo has successfully raised a total of $20.75M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $2.25 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $2.2M
-
First Round
First Round
(08 Jun 2021)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series A - EvoEndo | Valuation |
investors |
|
| Apr, 2023 | Amount | Series A - EvoEndo | Valuation | Gastro , Varia |
|
| Apr, 2022 | Amount | Series A - EvoEndo | Valuation | TLP Invest |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in EvoEndo
EvoEndo has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Gastro, Varia Ventures and TLP Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A gastroenterology organization is based in the United States.
|
Founded Year | Domain | Location | |
|
Venture capital funds are managed by Varia Ventures.
|
Founded Year | Domain | Location | |
|
Capital is invested by TLP Investments for economic and social impact.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by EvoEndo
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - EvoEndo
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evoendo Comparisons
Competitors of EvoEndo
EvoEndo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Auris Health, MedInTech, Karl Storz, Wooptix and Aohua Endoscopy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Robotic microsurgical systems for endoscopy are developed.
|
|
| domain | founded_year | HQ Location |
Medical device technologies are developed with AI for diagnostics.
|
|
| domain | founded_year | HQ Location |
Endoscopic instruments, devices, and camera systems are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Application that allows 3D capture using single standard camera
|
|
| domain | founded_year | HQ Location |
Endoscopic devices and accessories are developed for medical use.
|
|
| domain | founded_year | HQ Location |
Endoscopic medical devices are designed and manufactured for surgical applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evoendo
Frequently Asked Questions about EvoEndo
When was EvoEndo founded?
EvoEndo was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Where is EvoEndo located?
EvoEndo is headquartered in Englewood, United States. It is registered at Englewood, New Jersey, United States.
Who is the current CEO of EvoEndo?
Jonathan Hartmann is the current CEO of EvoEndo.
Is EvoEndo a funded company?
EvoEndo is a funded company, having raised a total of $20.75M across 4 funding rounds to date. The company's 1st funding round was a Series A of $8.4M, raised on Jun 08, 2021.
What does EvoEndo do?
EvoEndo is dedicated to providing innovative sedation-free endoscopy systems, primarily for pediatric and adult patients. The company offers the FDA-cleared EvoEndo Endoscopy System, designed for transnasal and transoral procedures without sedation. Solutions are developed to enhance patient experience by reducing risks and recovery time. The healthcare sector is served through advanced medical devices that align with evolving care standards, such as the 2025 ACG Guidelines for Eosinophilic Esophagitis (EoE).
Who are the top competitors of EvoEndo?
EvoEndo's top competitors include Auris Health, Wooptix and UnivLabs.
What products or services does EvoEndo offer?
EvoEndo offers EvoEndo Endoscopy System and Ultra-Thin Endoscopes.
Who are EvoEndo's investors?
EvoEndo has 3 investors. Key investors include Gastro, Varia Ventures, and TLP Investments.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.